109229
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
异甘草素的药理潜力及给药策略：提高生物利用度的挑战与进展
Authors Tang S, Deng Z, Ou M, Wang Z
Received 16 April 2025
Accepted for publication 5 September 2025
Published 5 November 2025 Volume 2025:19 Pages 9879—9911
DOI https://doi.org/10.2147/DDDT.S534713
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Solomon Tadesse Zeleke
Shuwei Tang,1,2,* Ziqing Deng,2 Mingjie Ou,2 Zhuxian Wang1,*
1Dermatology Hospital, Southern Medical University, Guangzhou, 510091, People’s Republic of China; 2School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhuxian Wang, Email wangzhuxian8998@163.com
Abstract: Isoliquiritigenin (ISLT), a bioactive and typical chalcones ingredient isolated from the root of licorice, has shown various pharmacological properties, including antitumor, anti-inflammatory and antioxidant activities. It is extensively utilized in the management of tumors, diabetes mellitus, dermatological disorders, and other therapeutic applications. Although ISLT has been globally recognized for its health benefits, its oral administration is still restricted by sparing water solubility, poor bioavailability, and slow dissolution in the intestine. For topical application, deficiencies include poor transdermal absorption and low skin permeability. Therefore, optimizing drug delivery systems and improving its bioavailability are considered a productive platform to solve these challenges of ISLT, but detailed strategies have not yet been systematically organized. This review first comprehensively summarizes the pharmacological activities, inherent mechanisms and therapeutic potentials of ISLT. Next, it describes programs to improve permeability and bioavailability in oral and transdermal drug delivery, such as nanocomposites, nanoemulsions, cyclodextrin complexes, and exosomes, as well as the use of chemical permeation enhancers. The applications of multiple administration routes and different formulations for enhanced bioavailability are exclusively compared. Additionally, new solutions such as ISLT derivatives and exosomes were proposed, aiming to address the limitations of ISLT and providing new ideas for its further application. In summary, this review offers comprehensive reference and theoretical support for the optimization and enhancement of the bioavailability for other natural flavonoid ingredients.
Keywords: isoliquiritigenin, drug delivery systems, transdermal delivery, bioavailability, pharmacological activities, oral delivery
1Dermatology Hospital, Southern Medical University, Guangzhou, 510091, People’s Republic of China; 2School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhuxian Wang, Email wangzhuxian8998@163.com
Abstract: Isoliquiritigenin (ISLT), a bioactive and typical chalcones ingredient isolated from the root of licorice, has shown various pharmacological properties, including antitumor, anti-inflammatory and antioxidant activities. It is extensively utilized in the management of tumors, diabetes mellitus, dermatological disorders, and other therapeutic applications. Although ISLT has been globally recognized for its health benefits, its oral administration is still restricted by sparing water solubility, poor bioavailability, and slow dissolution in the intestine. For topical application, deficiencies include poor transdermal absorption and low skin permeability. Therefore, optimizing drug delivery systems and improving its bioavailability are considered a productive platform to solve these challenges of ISLT, but detailed strategies have not yet been systematically organized. This review first comprehensively summarizes the pharmacological activities, inherent mechanisms and therapeutic potentials of ISLT. Next, it describes programs to improve permeability and bioavailability in oral and transdermal drug delivery, such as nanocomposites, nanoemulsions, cyclodextrin complexes, and exosomes, as well as the use of chemical permeation enhancers. The applications of multiple administration routes and different formulations for enhanced bioavailability are exclusively compared. Additionally, new solutions such as ISLT derivatives and exosomes were proposed, aiming to address the limitations of ISLT and providing new ideas for its further application. In summary, this review offers comprehensive reference and theoretical support for the optimization and enhancement of the bioavailability for other natural flavonoid ingredients.
Keywords: isoliquiritigenin, drug delivery systems, transdermal delivery, bioavailability, pharmacological activities, oral delivery